EDGAR Filing Documents for 0001171843-19-004042

Form 8-K - Current report:

SEC Accession No. 0001171843-19-004042

Filing Date

2019-06-18

Accepted

2019-06-18 16:00:37

Documents

Period of Report

2019-06-13

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	f8k_061819.htm	8-K	30049
2	EXHIBIT 10.1	exh_101.htm	EX-10.1	74503
3	EXHIBIT 10.2	exh_102.htm	EX-10.2	24161
4	EXHIBIT 10.3	exh_103.htm	EX-10.3	73381
5	EXHIBIT 10.4	exh_104.htm	EX-10.4	39899
6	PRESS RELEASE	exh_991.htm	EX-99.1	9251
	Complete submission text file	0001171843-19-004042.txt		252656

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 19903687
SIC: 2834 Pharmaceutical Preparations